Abbott's (ABT) Assert-IQ Cardiac Monitor Receives CE Mark
https://www.zacks.com/stock/news/2246922/abbott-s-abt-assert-iq-cardiac-monitor-receives-ce-mark?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2246922
Mar 27, 2024 - Abbott's (ABT) Assert-IQ ICM enables regular monitoring for abnormal heart rhythms, as well as technologies to improve data management and workflow.
0
Celanese (CE) Gets ISCC-Certified for Low Carbon CCU Methanol
https://www.zacks.com/stock/news/2245584/celanese-ce-gets-iscc-certified-for-low-carbon-ccu-methanol?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2245584
Mar 25, 2024 - Celanese (CE) now offers low-carbon choices to customers across its Acetyl Chain and Engineered Materials products under the ECO-CC name.
0
Eastman Chemical (EMN) Gains on Cost Cuts and Innovation
https://www.zacks.com/stock/news/2245564/eastman-chemical-emn-gains-on-cost-cuts-and-innovation?cid=CS-ZC-FT-analyst_blog|zer_report_update-2245564
Mar 25, 2024 - Eastman Chemical (EMN) benefits from cost-management actions, acquisitions and innovation amid challenges from soft demand and consumer de-stocking in certain markets.
0
Here's Why You Should Hold Onto Celanese (CE) Stock For Now
https://www.zacks.com/stock/news/2244133/here-s-why-you-should-hold-onto-celanese-ce-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2244133
Mar 21, 2024 - While Celanese (CE) faces headwinds from demand softness and pricing pressures, it gains on strategic acquisitions and productivity measures.
0
CES Energy Solutions Corp. (CESDF) Q4 2023 Earnings Call Transcript
https://seekingalpha.com/article/4675387-ces-energy-solutions-corp-cesdf-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Mar 01, 2024 - CES Energy Solutions Corp. (OTCPK:CESDF) Q4 2023 Earnings Conference Call March 1, 2024 11:00 AM ETCompany ParticipantsAnthony Aulicino - Chief Financial...
0
Celanese (CE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2228918/celanese-ce-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228918
Feb 20, 2024 - While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Insulet's (PODD) Omnipod 5 Gets CE Mark for Added Compatibility
https://www.zacks.com/stock/news/2223400/insulet-s-podd-omnipod-5-gets-ce-mark-for-added-compatibility?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2223400
Feb 08, 2024 - Insulet's (PODD) tubeless automated insulin delivery system's CE mark approval with multiple CGM sensor brands is likely to serve a wider patient pool.
0
Insulet gets CE Mark for Omnipod 5 with FreeStyle Libre 2 sensor
https://seekingalpha.com/news/4063877-insulet-gets-ce-mark-for-omnipod-5-with-freestyle-libre-2-sensor?source=feed_sector_healthcare
Feb 07, 2024 - Insulet (PODD) has received European approval for its Omnipod 5 insulin delivery system integrated with Abbott's (ABT) FreeStyle Libre 2 Plus sensor for type 1 diabetes.
0
InspireMD's (NSPR) CE Mark Recertification to Boost CGuard EPS
https://www.zacks.com/stock/news/2221179/inspiremd-s-nspr-ce-mark-recertification-to-boost-cguard-eps?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221179
Feb 05, 2024 - InspireMD's (NSPR) CE Mark Recertification under MDR is likely to help the company boost the CGuard EPS for carotid artery revascularization care along with advancing with new products.
0
Eastman Chemical (EMN) Gains on Cost Cuts and Innovation
https://www.zacks.com/stock/news/2216558/eastman-chemical-emn-gains-on-cost-cuts-and-innovation?cid=CS-ZC-FT-analyst_blog|zer_report_update-2216558
Jan 26, 2024 - Eastman Chemical (EMN) benefits from cost-management actions and innovation amid challenges from soft demand and consumer de-stocking in certain markets.
0
Page 1>